Detalles de la búsqueda
1.
Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Rheumatol Int
; 37(9): 1469-1479, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28597306
2.
Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation.
Ann Rheum Dis
; 73(1): 161-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23300117
3.
Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis.
Ann Rheum Dis
; 73(3): 616-23, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23625984
4.
Effect of golimumab on carotid atherosclerotic disease measures and cardiovascular events in inflammatory arthritides.
J Clin Rheumatol
; 20(1): 1-10, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356481
5.
Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
Ann Rheum Dis
; 72(9): 1481-7, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22993227
6.
Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
Rheumatology (Oxford)
; 52(7): 1214-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23418046
7.
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Rheumatology (Oxford)
; 52(10): 1845-55, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23838027
8.
Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
Arthritis Rheum
; 64(7): 2068-77, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22238071
9.
Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
Arthritis Rheum
; 64(8): 2504-17, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22378566
10.
Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.
Arthritis Rheum
; 63(12): 3712-22, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22127693
11.
The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.
Arthritis Rheum
; 63(5): 1200-10, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21305524
12.
Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.
Ann Rheum Dis
; 70(11): 1968-74, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21784729
13.
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years.
Ann Rheum Dis
; 70(9): 1631-40, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21708910
14.
Predicting the outcome of ankylosing spondylitis therapy.
Ann Rheum Dis
; 70(6): 973-81, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21402563
15.
Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis.
Ann Rheum Dis
; 70(12): 2126-30, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21926186
16.
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study.
Rheumatology (Oxford)
; 50(11): 2061-70, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21873264
17.
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Lancet
; 374(9685): 210-21, 2009 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-19560810
18.
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study.
Ann Rheum Dis
; 69(6): 1129-35, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20444749
19.
A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate.
J Pharmacokinet Pharmacodyn
; 37(4): 309-21, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20635122
20.
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
Ann Intern Med
; 146(9): 621-30, 2007 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17470830